BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15891564)

  • 1. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia.
    Ercan TE; Soycan LY; Apak H; Celkan T; Ozkan A; Akdenizli E; Kasapçopur O; Yildiz I
    J Pediatr Hematol Oncol; 2005 May; 27(5):273-7. PubMed ID: 15891564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of immune response following immunization with DTP/Td and MMR vaccines in children treated for acute lymphoblastic leukemia.
    Koochakzadeh L; Khosravi MH; Pourakbari B; Hosseinverdi S; Aghamohammadi A; Rezaei N
    Pediatr Hematol Oncol; 2014 Oct; 31(7):656-63. PubMed ID: 25007393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
    Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
    Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to simultaneous administration of a combined measles, mumps and rubella vaccine with booster doses of diphtheria-tetanus and poliovirus vaccine.
    Giammanco G; Li Volti S; Salemi I; Giammanco Bilancia G; Mauro L
    Eur J Epidemiol; 1993 Mar; 9(2):199-202. PubMed ID: 8519358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines.
    Rothstein EP; Bernstein HH; Glode MP; Laussucq S; Nonenmacher J; Long SS; Hackell JG
    Am J Dis Child; 1993 Aug; 147(8):854-7. PubMed ID: 8394646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.
    Nakayama T; Aizawa C; Kuno-Sakai H
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):321-5. PubMed ID: 9949325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
    Zengin E; Sarper N
    Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
    Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
    Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revaccination of children after completion of standard chemotherapy for acute leukemia.
    Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
    Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response after post-chemotherapy booster diphtheria-tetanus-pertussis vaccine in pediatric oncology patients.
    Cheng FW; Leung TF; Chan PK; Lee V; Shing MK; Chik KW; Yuen PM; Li CK
    Pediatr Blood Cancer; 2009 Feb; 52(2):248-53. PubMed ID: 18937325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-specific immunological effects of selected routine childhood immunisations: systematic review.
    Kandasamy R; Voysey M; McQuaid F; de Nie K; Ryan R; Orr O; Uhlig U; Sande C; O'Connor D; Pollard AJ
    BMJ; 2016 Oct; 355():i5225. PubMed ID: 27737830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
    Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX.
    Shinefield HR; Black SB; Staehle BO; Adelman T; Ensor K; Ngai A; White CJ; Bird SR; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 1998 Nov; 17(11):980-5. PubMed ID: 9849978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.
    Rosen JB; Breman JG; Manclark CR; Meade BD; Collins WE; Lobel HO; Saliou P; Roberts JM; Campaoré P; Miller MA
    Malar J; 2005 Nov; 4():53. PubMed ID: 16271153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.
    Deforest A; Long SS; Lischner HW; Girone JA; Clark JL; Srinivasan R; Maguire TG; Diamond SA; Schiller RP; Rothstein EP
    Pediatrics; 1988 Feb; 81(2):237-46. PubMed ID: 3340474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China.
    Li YT; Luo XQ; Zhong XB; Cai LM; Zhu LP; Chen XQ; Wang KC; Chen ZG
    Vaccine; 2020 May; 38(23):3960-3967. PubMed ID: 32321685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
    Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
    Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
    Lagos R; Kotloff K; Hoffenbach A; San Martin O; Abrego P; Ureta AM; Pines E; Blondeau C; Bailleux F; Levine MM
    Pediatr Infect Dis J; 1998 Apr; 17(4):294-304. PubMed ID: 9576383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.